Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis <i>in vivo</i>-Reference-Cited by-同舟云学术

Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis in vivo

Published:2024-02-20 Issue: Volume: Page:1-12
ISSN:0898-2104
Container-title:Journal of Liposome Research
language:en
Short-container-title:Journal of Liposome Research

Author:

Sesarman Alina¹,Luput Lavinia¹,Rauca Valentin-Florian¹²,Patras Laura¹,Licarete Emilia¹³,Meszaros Marta-Szilvia¹,Dume Bogdan Razvan⁴,Negrea Giorgiana⁴,Toma Vlad-Alexandru¹⁵,Muntean Dana⁶,Porfire Alina⁶,Banciu Manuela¹

Affiliation:

1. Department of Molecular Biology and Biotechnology, and Center of Systems Biology, Biodiversity and Bioresources, Faculty of Biology and Geology, Babes-Bolyai University, Cluj-Napoca, Romania

2. Department of Dermatology and Allergology, School of Medicine, Technical University of Munich, Munich, Germany

3. Molecular Biology Centre, Institute for Interdisciplinary Research in Bio-Nano-Sciences of Babes-Bolyai University, Cluj-Napoca, Romania

4. Doctoral School in Integrative Biology, Faculty of Biology and Geology, “Babes-Bolyai” University, Cluj-Napoca, Romania

5. Department of Experimental Biology and Biochemistry, nstitute of Biological Research, branch of NIRDBS Bucharest, Cluj-Napoca, Romania

6. Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania

Funder

Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii

Universitatea Babeș-Bolyai

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/08982104.2024.2315452

Reference67 articles.

1. The Rapid Rise in Cutaneous Melanoma Diagnoses

2. Multi-organ landscape of therapy-resistant melanoma

3. Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy

4. Integrated analysis reveals the pivotal interactions between immune cells in the melanoma tumor microenvironment

5. Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state